Skip to content

Study · Animal study (in vivo) · violet-eared waxbill · 1998

1 result

Vasotocin and vasoactive intestinal polypeptide modulate aggression in a territorial songbird, the violet-eared waxbill (Estrildidae: Uraeginthus granatina).

Goodson JL

General and comparative endocrinology1 Aug 1998Cited by 100 (Europe PMC)

PMID9679095 (opens in a new tab)DOI10.1006/gcen.1998.7112 (opens in a new tab)PepBankPUB-09679095
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In violet-eared waxbills, septal VIP infusions significantly facilitated aggression.

    In plain wordsIn violet-eared waxbills, VIP infused into the brain septum increased aggressive behaviour.

    Peptide
    Vasoactive intestinal peptide (VIP, aviptadil)
    Outcome
    IncreaseAggressive behaviour after VIP infusion
    Study

    violet-eared waxbilln: not reported in source

    Outcome group
    Social behavior and cognition · Nervous system and cognition
    Studied dose
    Dose not stated · septal infusionAs given in this study (violet-eared waxbill).

    Source sentences

    Summary
    but infusions of vasoactive intestinal polypeptide (VIP) significantly facilitated aggression.
    1 context sentence
    Summary · context
    In order to determine whether this difference may be related to the territorial and colonial social organizations of these two species, the effect of AVT infusions was examined in a territorial Estrildid species, the violet-eared waxbill (Uraeginthus granatina).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 12:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 12:41 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.